Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer

Better biomarkers are needed to improve the efficacy of immune checkpoint inhibitors in lung adenocarcinoma (LUAD) treatment. We investigated the plasma extracellular vesicle (EV)‐derived long RNAs (exLRs) in unresectable/advanced LUAD to explore biomarkers for immunochemotherapy. Seventy‐four LUAD...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Jiatao, Lai, Hongyan, Liu, Chang, Zhang, Xin, Ou, Qiuxiang, Li, Qiaojuan, Li, Yan, Wang, Zhen, Liu, Cuicui, Wu, Xianghua, Wang, Huijie, Yu, Hui, Sun, Si, Zhao, Xinmin, Hu, Zhihuang, Zhang, Yao, Lin, Ying, Yu, Bo, Huang, Shenglin, Wang, Jialei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323081/
https://www.ncbi.nlm.nih.gov/pubmed/37014183
http://dx.doi.org/10.1111/cas.15804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323081/
https://www.ncbi.nlm.nih.gov/pubmed/37014183
http://dx.doi.org/10.1111/cas.15804

Ejemplares similares